New drug tested to protect kidneys in overweight patients

NCT ID NCT05936151

Completed Disease control Sponsor: Eli Lilly and Company Source: ClinicalTrials.gov ↗

Summary

This study tested whether an investigational drug called retatrutide could improve kidney function in people who are overweight or obese and have chronic kidney disease, with or without type 2 diabetes. The 31-week trial involved 146 participants and compared the drug's effects to a placebo. Researchers measured changes in key kidney health markers, including filtration rate and protein in urine, to see if the treatment could help control the progression of kidney disease.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

9109-0126 Quebec Inc.

Montreal, Quebec, H4N 2W2, Canada
Addenbrooke's Hospital

Cambridge, Cambridgeshire, CB2 2QQ, United Kingdom
Azienda Ospedaliera Universitaria Pisana

Pisa, Tuscany, 56126, Italy
Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII

Bergamo, 24127, Italy
Care Access - 801 South Power Road, Mesa

Mesa, Arizona, 85206, United States
Catalina Research Institute, LLC

Montclair, California, 91763, United States
Centricity Research Brampton Endocrinology

Brampton, Ontario, L6S 0C6, Canada
Centro Cardiologico Monzino

Milan, Milano, 20138, Italy
Circulate Cardiac & Vascular Centre

Burlington, Ontario, L7M 1K9, Canada
City Hospital, Nottingham University Hospitals NHS Trust

Nottingham, NG5 1PB, United Kingdom
Cleveland Clinic

Cleveland, Ohio, 44195, United States
Clínica nuevas Tecnologías en Diabetes y Endocrinología (NTDE)

Seville, 41003, Spain
Diex Recherche Joliette

Joliette, Quebec, J6E 6A9, Canada
Dr. Anil K. Gupta Medicine Professional Corporation

Toronto, Ontario, M9V 4B4, Canada
Endocrine Ips, Pllc

Houston, Texas, 77079, United States
Fadia El Boreky Medicine

Waterloo, Ontario, N2J 1C4, Canada
FutureMeds Teesside - Middlefield Centre

Stockton-on-Tees, Durham County, TS19 8PE, United Kingdom
Futuremeds-Newcastle

Newcastle, England, United Kingdom
Great Lakes Clinical Trials - Ravenswood

Chicago, Illinois, 60640, United States
Headlands Research - Scottsdale

Scottsdale, Arizona, 85260, United States
Hope Clinical Research, Inc.

Canoga Park, California, 91303, United States
Hospital Clinico de Valencia

Valencia, Valenciana, Comunitat, 46010, Spain
Hospital Universitario Doctor Peset

Valencia, Valenciana, Comunitat, 46017, Spain
Indiana University Health University Hospital

Indianapolis, Indiana, 46202, United States
Medical Advancement Centers of Arizona

Tempe, Arizona, 85283, United States
NYU Langone Hospital - Long Island

Mineola, New York, 11501, United States
North Middlesex Hospital

London, London, City of, N18 1QX, United Kingdom
North York Diagnostic and Cardiac Centre

North York, Ontario, M6B 3H7, Canada
Ospedale San Raffaele

Milan, 20132, Italy
Palm Research Center Tenaya

Las Vegas, Nevada, 89128, United States
Peninsula Research Associates

Rolling Hills Estates, California, 90274, United States
Prime Health and Wellness/SKYCRNG

Fayette, Mississippi, 39069, United States
Royal London Hospital

London, England, E1 1BB, United Kingdom
Stouffville Medical Research Institute Inc.

Stouffville, Ontario, L4A 1H2, Canada
Suncoast Clinical Research, Inc.

New Port Richey, Florida, 34652, United States
Teradan Clinical Trials, LLC

Brandon, Florida, 33511, United States
The Institute for Liver Health II dba Arizona Clinical Trials - Mesa

Chandler, Arizona, 85225, United States
Tranquility Research

Webster, Texas, 77598, United States
University of Colorado Anschutz Medical Campus

Aurora, Colorado, 80045, United States
Vascular Research Team

Salford, Greater Manchester, M6 8HD, United Kingdom
Viacar Recherche Clinique

Greenfield Park, Quebec, J4V 2G8, Canada
Victorium Clinical Research - Houston

Houston, Texas, 77024, United States

Conditions

Explore the condition pages connected to this study.

CKD OVERWEIGHT OR OBESITY TYPE 2 DIABETES